South African pharmaceutical group Aspen Pharmacare has acquired Nestle’s infant milk factory in Mexico and licences for some of its brands in Latin America.
The latest deal between Aspen and Nestle will see the South African group gain licence rights to intellectual property, a production facility in Vallejo in Mexico, and shares in the businesses conducted by Nestlé and Pfizer in Latin America, Aspen said.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The transaction follows a similar deal in April that saw Aspen buy licences for some of Nestle’s infant milk brands in southern Africa and Australia for A$215m.
The agreement includes the exclusive right of use of the Nestlé S26 Gold and SMA trademarks for ten years in South and Central America. It will also have the right to co-brand the licensed products over the same period.
The revenue for the infant nutrition businesses totalled US$187m in 2012.
Australian competition authorities have approved the acquisition, while South African and Namibian approval is pending, Aspen said.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
